These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 8386406)
21. Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients. Ontañón J; Muro M; García-Alonso AM; Minguela A; Torío A; Bermejo J; Pons JA; Campos M; Alvarez-López MR Transplantation; 1998 Apr; 65(8):1047-53. PubMed ID: 9583864 [TBL] [Abstract][Full Text] [Related]
22. Differentiation of cytomegalovirus infection from acute rejection using renal allograft fine needle aspirates. Nast CC; Wilkinson A; Rosenthal JT; Barba L; Bretan PN; Beaumont P; Danovitch GM J Am Soc Nephrol; 1991 May; 1(11):1204-11. PubMed ID: 1657240 [TBL] [Abstract][Full Text] [Related]
23. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients. Herzberg GZ; Rossi AF; Courtney M; Gelb BD J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760 [TBL] [Abstract][Full Text] [Related]
24. Co-infection and clinical impact of human herpesvirus 5 and 6 in liver transplantation. Sampaio AM; Guardia AC; Milan A; Sasaki AN; Andrade PD; Bonon SH; Stucchi RS; Botelho Costa SC; Boin IF Transplant Proc; 2012 Oct; 44(8):2455-8. PubMed ID: 23026619 [TBL] [Abstract][Full Text] [Related]
25. Effect of donor-recipient cytomegalovirus serologic status on outcomes in simultaneous kidney-pancreas transplant recipients. Stratta RJ; Alloway RR; Lo A; Hodge EE; Transplant Proc; 2004 May; 36(4):1082-3. PubMed ID: 15194376 [TBL] [Abstract][Full Text] [Related]
26. Serological responses to cytomegalovirus during renal transplant rejection. Sherlock CH; Denegri JF; Ashley RL Transplantation; 1991 Aug; 52(2):272-5. PubMed ID: 1651576 [TBL] [Abstract][Full Text] [Related]
27. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation. Clark G; Walsh G; Deshpande P; Koffman G Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256 [TBL] [Abstract][Full Text] [Related]
28. Cytomegalovirus infection and disease following renal transplantation: preliminary report of incidence and potential risk factors. Taherimahmoudi M; Ahmadi H; Baradaran N; Montaser-Kouhsari L; Salem S; Mehrsai A; Kalantar E; Jahani Y; Pourmand G Transplant Proc; 2009 Sep; 41(7):2841-4. PubMed ID: 19765452 [TBL] [Abstract][Full Text] [Related]
29. Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection. van den Berg AP; Klompmaker IJ; Haagsma EB; Peeters PM; Meerman L; Verwer R; The TH; Slooff MJ Clin Transplant; 1996 Apr; 10(2):224-31. PubMed ID: 8664524 [TBL] [Abstract][Full Text] [Related]
31. Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients. Humar A; Gillingham KJ; Payne WD; Dunn DL; Sutherland DE; Matas AJ Transplantation; 1999 Dec; 68(12):1879-83. PubMed ID: 10628768 [TBL] [Abstract][Full Text] [Related]
32. Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies. Ringdén O; Remberger M; Carlens S; Hagglund H; Mattsson J; Aschan J; Lönnqvist B; Klaesson S; Winiarski J; Dalianis T; Olerup O; Sparrelid E; Elmhorn-Rosenborg A; Svahn BM; Ljungman P Transplantation; 1998 Sep; 66(5):620-5. PubMed ID: 9753343 [TBL] [Abstract][Full Text] [Related]
33. Cytomegalovirus seromismatching increases the risk of acute renal allograft rejection. McLaughlin K; Wu C; Fick G; Muirhead N; Hollomby D; Jevnikar A Transplantation; 2002 Sep; 74(6):813-6. PubMed ID: 12364861 [TBL] [Abstract][Full Text] [Related]
34. Expression of HLA-DR on T lymphocytes following renal transplantation, and association with graft-rejection episodes and cytomegalovirus infection. van Es A; Baldwin WM; Oljans PJ; Tanke HJ; Ploem JS; van Es LA Transplantation; 1984 Jan; 37(1):65-9. PubMed ID: 6320508 [TBL] [Abstract][Full Text] [Related]
35. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis. Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451 [TBL] [Abstract][Full Text] [Related]
37. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients. Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686 [TBL] [Abstract][Full Text] [Related]
38. Prospective study of human betaherpesviruses after renal transplantation: association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection. Kidd IM; Clark DA; Sabin CA; Andrew D; Hassan-Walker AF; Sweny P; Griffiths PD; Emery VC Transplantation; 2000 Jun; 69(11):2400-4. PubMed ID: 10868648 [TBL] [Abstract][Full Text] [Related]
39. Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients. Grossi P; Minoli L; Percivalle E; Irish W; Vigano M; Gerna G Transplantation; 1995 Mar; 59(6):847-51. PubMed ID: 7701579 [TBL] [Abstract][Full Text] [Related]